tradingkey.logo

Bio Rad Laboratories Inc

BIO
319.550USD
+15.080+4.95%
終値 10/31, 16:00ET15分遅れの株価
8.62B時価総額
損失額直近12ヶ月PER

Bio Rad Laboratories Inc

319.550
+15.080+4.95%

詳細情報 Bio Rad Laboratories Inc 企業名

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Incの企業情報

企業コードBIO
会社名Bio Rad Laboratories Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Norman D. Schwartz
従業員数7700
証券種類Ordinary Share
決算期末Mar 17
本社所在地1000 Alfred Nobel Dr
都市HERCULES
証券取引所NYSE Consolidated
United States of America
郵便番号94547
電話番号15107247000
ウェブサイトhttps://www.bio-rad.com/
企業コードBIO
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Norman D. Schwartz

Bio Rad Laboratories Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
データなし
地域別USD
会社名
収益
比率
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
事業別
地域別
データなし

株主

更新時刻: Thu, Oct 30
更新時刻: Thu, Oct 30
株主統計
種類
株主統計
株主統計
比率
First Eagle Investment Management, L.L.C.
11.49%
The Vanguard Group, Inc.
8.41%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
7.05%
Schwartz (Norman D)
6.36%
他の
58.55%
株主統計
株主統計
比率
First Eagle Investment Management, L.L.C.
11.49%
The Vanguard Group, Inc.
8.41%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
7.05%
Schwartz (Norman D)
6.36%
他の
58.55%
種類
株主統計
比率
Investment Advisor/Hedge Fund
42.47%
Investment Advisor
38.94%
Individual Investor
8.27%
Corporation
8.13%
Hedge Fund
7.04%
Research Firm
1.67%
Pension Fund
1.24%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.63%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
1080
20.35M
92.90%
-2.73M
2025Q2
1116
24.14M
109.77%
-3.54M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
First Eagle Investment Management, L.L.C.
2.52M
11.45%
+223.05K
+9.72%
Jun 30, 2025
The Vanguard Group, Inc.
1.84M
8.38%
-59.61K
-3.13%
Jun 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.1%
--
--
May 01, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
7.02%
-98.58K
-6.00%
Jun 30, 2025
Schwartz (Norman D)
447.98K
2.04%
+5.20K
+1.17%
Sep 06, 2025
Dimensional Fund Advisors, L.P.
999.57K
4.55%
+122.53K
+13.97%
Jun 30, 2025
Veritas Asset Management LLP
863.14K
3.92%
-49.98K
-5.47%
Jun 30, 2025
Ariel Investments, LLC
818.62K
3.72%
+93.96K
+12.97%
Jun 30, 2025
EARNEST Partners, LLC
605.89K
2.75%
+6.26K
+1.04%
Jun 30, 2025
State Street Investment Management (US)
584.37K
2.66%
-110.15K
-15.86%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: 7 hours ago
更新時刻: 7 hours ago
銘柄名
比率
Parnassus Value Select ETF
3.15%
First Trust Indxx Medical Devices ETF
2.2%
ROBO Global Healthcare Technology & Innovation ETF
1.46%
Schwab Ariel Opportunities ETF
1.25%
FPA Global Equity ETF
1.21%
First Eagle Global Equity ETF
1.08%
Pacer US Export Leaders ETF
1.01%
WisdomTree BioRevolution Fund
0.85%
iShares Health Innovation Active ETF
0.84%
Harbor Health Care ETF
0.75%
詳細を見る
Parnassus Value Select ETF
比率3.15%
First Trust Indxx Medical Devices ETF
比率2.2%
ROBO Global Healthcare Technology & Innovation ETF
比率1.46%
Schwab Ariel Opportunities ETF
比率1.25%
FPA Global Equity ETF
比率1.21%
First Eagle Global Equity ETF
比率1.08%
Pacer US Export Leaders ETF
比率1.01%
WisdomTree BioRevolution Fund
比率0.85%
iShares Health Innovation Active ETF
比率0.84%
Harbor Health Care ETF
比率0.75%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI